Transcription profiling of human breast cancer samples that were treated with tamoxifen identifier a 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy

ABSTRACT: Classification of tamixifen-treated breast cancer patients into high and low risk groups using the 76-gene signature Experiment Overall Design: 136 breast cancer samples that were treated with tamoxifen were classified using the 76-gene signature

ORGANISM(S): Homo sapiens

SUBMITTER: Jack Yu 

PROVIDER: E-GEOD-12093 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress